Clarity Pharmaceuticals Ltd Stock
Stocks
CU6
AU0000165375
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
13:10:11 30/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1.570 AUD | -5.99% |
|
-.--% | -53.55% |
| Market Cap | 586M 412M 369M 339M 308M 575M 39.13B 4.05B 1.63B 20.58B 1.55B 1.51B 64.91B | P/E 2027 * |
-4.96x | P/E 2028 * | -5.9x |
|---|---|---|---|---|---|
| Enterprise Value | 522M 367M 329M 302M 274M 512M 34.85B 3.61B 1.45B 18.33B 1.38B 1.35B 57.82B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 15.1x |
| Free-Float |
78.88% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| CU6 | Delayed | |
OTC Markets
| CLRPF | Delayed | |
|
Tradegate
| 1F4 | Real-time | |
|
Deutsche Boerse AG
| 1F4 | Delayed |
| 1 day | -5.99% | ||
| 1 month | -25.24% | ||
| 3 months | -33.76% | ||
| 6 months | -44.52% | ||
| Current year | -53.55% |
| 1 week | 1.54 |  | 1.69 |
| 1 month | 1.52 | | 2.14 |
| Current year | 1.52 | | 4.26 |
| 1 year | 1.52 | | 5.1 |
| 3 years | 1 | | 8.98 |
| 5 years | 0.36 | | 8.98 |
| 10 years | 0.36 | | 8.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michelle Parker
CEO | Chief Executive Officer | - | 11/10/2024 |
Matthew Harris
CEO | Chief Executive Officer | - | 01/01/2010 |
David Green
DFI | Director of Finance/CFO | - | 04/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Alan Taylor
CHM | Chairman | - | 01/11/2013 |
Rosanne Robinson
BRD | Director/Board Member | - | 01/10/2010 |
Chris Roberts
BRD | Director/Board Member | 72 | 29/03/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 22/4/26 | Sell | Chief Executive Officer | 360,896 | 0.0969% | ||
| 28/11/25 | Free | Chief Operating Officer | 199,909 | 0.0537% | ||
| 28/11/25 | Free | Chief Operating Officer | 287,530 | 0.0773% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.99% | -.--% | -67.96% | +49.52% | 412M | |
| -0.62% | -1.87% | +42.87% | +64.15% | 63.77B | |
| +0.35% | +3.20% | +14.40% | +81.76% | 56.37B | |
| +0.53% | +1.96% | +16.24% | +103.35% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +47.83% | 44.06B | |
| -0.33% | -1.93% | +19.28% | +98.80% | 42.11B | |
| +0.55% | +2.31% | +225.14% | +866.21% | 41B | |
| +3.27% | +47.96% | +112.84% | +96.58% | 34.92B | |
| +1.22% | -1.44% | +14.57% | +46.95% | 32.82B | |
| +0.89% | +20.55% | -40.62% | +349.24% | 24.7B | |
| Average | -0.29% | +6.79% | +36.02% | +180.44% | 39.48B | |
| Weighted average by Cap. | +0.17% | +5.44% | +47.87% | +176.54% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 33.03M 23.24M 20.81M 19.15M 17.35M 32.43M 2.21B 228M 91.65M 1.16B 87.22M 85.36M 3.66B |
| Net income | -121M -84.92M -76.05M -69.95M -63.38M -118M -8.06B -834M -335M -4.24B -319M -312M -13.38B | -101M -71.11M -63.69M -58.58M -53.08M -99.22M -6.75B -699M -280M -3.55B -267M -261M -11.2B |
| Net Debt | -64M -45.03M -40.33M -37.09M -33.61M -62.82M -4.28B -442M -178M -2.25B -169M -165M -7.09B | -87M -61.21M -54.82M -50.42M -45.69M -85.4M -5.81B -601M -241M -3.06B -230M -225M -9.64B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | A$1.570 | -5.99% | 2,982,072 |
| 29/10/26 | A$1.670 | +6.71% | 4,411,106 |
| 28/10/26 | A$1.565 | +0.97% | 4,140,307 |
| 27/10/26 | A$1.550 | -1.59% | 3,714,069 |
| 26/10/26 | A$1.575 | +0.32% | 3,615,863 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CU6 Stock
Select your edition
All financial news and data tailored to specific country editions
